{"filing":{"accession_number":"0001388658-26-000071","cik":"0001388658","ticker":"IRTC","company_name":"iRhythm Holdings, Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-05","primary_document":"irtc-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1388658/000138865826000071/irtc-20260805.htm"},"events":[{"id":24682,"run_id":22378,"accession_number":"0001388658-26-000071","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"iRhythm entered into a definitive merger agreement to acquire Vital Connect, Inc. for aggregate consideration of $287.5 million ($237.5 million cash plus $50 million in stock), with Vital Connect becoming a wholly owned subsidiary. The transaction requires HSR approval and stockholder approval, with expected close by end of 2026.","company_name":"iRhythm Holdings, Inc.","ticker":"IRTC","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":25326,"accession_number":"0001388658-26-000071","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"reasoning":"iRhythm entered into a definitive merger agreement to acquire Vital Connect, Inc. for aggregate consideration of $287.5 million ($237.5 million cash plus $50 million in stock). The disclosure explicitly describes the \"Agreement and Plan of Merger\" and the resulting \"Acquisition\" whereby Vital Connect will become a wholly owned subsidiary of iRhythm. This is a material acquisition transaction requiring HSR approval and stockholder approval, expected to close by end of 2026.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T00:36:18.205452+00:00","company_name":"","ticker":null,"filing_date":""},{"id":25327,"accession_number":"0001388658-26-000071","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 discloses an unregistered issuance of iRhythm Common Stock as partial consideration in an acquisition (the \"Acquisition\" and \"Merger Agreement\" referenced in Item 1.01). While the Item 3.02 section itself focuses on the equity issuance mechanics and Securities Act exemptions, the core material event is the acquisition transaction itself. The equity issuance is a component of the M\u0026A activity, making this a material acquisition disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T00:36:18.205452+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25326,"accession_number":"0001388658-26-000071","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"reasoning":"iRhythm entered into a definitive merger agreement to acquire Vital Connect, Inc. for aggregate consideration of $287.5 million ($237.5 million cash plus $50 million in stock). The disclosure explicitly describes the \"Agreement and Plan of Merger\" and the resulting \"Acquisition\" whereby Vital Connect will become a wholly owned subsidiary of iRhythm. This is a material acquisition transaction requiring HSR approval and stockholder approval, expected to close by end of 2026.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T00:36:18.205452+00:00","company_name":"iRhythm Holdings, Inc.","ticker":"IRTC","filing_date":"2026-08-06"},{"id":25327,"accession_number":"0001388658-26-000071","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 discloses an unregistered issuance of iRhythm Common Stock as partial consideration in an acquisition (the \"Acquisition\" and \"Merger Agreement\" referenced in Item 1.01). While the Item 3.02 section itself focuses on the equity issuance mechanics and Securities Act exemptions, the core material event is the acquisition transaction itself. The equity issuance is a component of the M\u0026A activity, making this a material acquisition disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T00:36:18.205452+00:00","company_name":"iRhythm Holdings, Inc.","ticker":"IRTC","filing_date":"2026-08-06"}]}